University of Tasmania
Browse

File(s) not publicly available

Australian report on pediatric medication issues

journal contribution
posted on 2023-05-22, 01:52 authored by Sean BeggsSean Beggs
Australian prescribers have faced many of the same issues as those in other developed countries in relation to medicines for children. Australia represents <1% of the world pharmaceutical market, with the pediatric market being a fraction of this. Thus, Australia’s ability to influence the global market has been seen as limited, and it had been hoped that Australian children would benefit from international efforts in the area of medicines for children. This, however, has not eventuated, with there being very little change in the availability of medications for children in Australia over the past 2 decades. A number of reviews have been undertaken looking at the issue of medication for children in Australia and what could be done. Recently, two significant events have occurred: the first is the establishment of a pediatric medicines advisory group by the Australian government and the second is the decision to fund the development of a national pediatric dosing reference. These events represent significant progress, but are only the first of many steps required to improve medications for children in the 'land of Oz' (Australia).

History

Publication title

Pediatric Drugs

Volume

11

Pagination

38-40

ISSN

1174-5878

Department/School

Tasmanian School of Medicine

Publisher

ADIS Int Ltd

Place of publication

New Zealand

Repository Status

  • Restricted

Socio-economic Objectives

Neonatal and child health

Usage metrics

    University Of Tasmania

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC